Catalent
CTLT
#1813
Rank
C$15.68 B
Marketcap
C$86.42
Share price
0.00%
Change (1 day)
6.87%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): C-$8.56

According to Catalent's latest financial reports the company's current EPS (TTM) is C-$8.62. In 2023 the company made an earnings per share (EPS) of C-$9.26 a decrease over its 2022 EPS that were of C$3.09.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$8.56-7.55%
2023C-$9.26-399.56%
2022C$3.09-30.58%
2021C$4.4579.67%
2020C$2.48114.12%
2019C$1.16-15%
2018C$1.3675.44%
2017C$0.78-22.97%
2016C$1.01-59.56%
2015C$2.49282.05%
2014C$0.65

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
C-$0.45-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C-$8.11-5.85%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
C-$1.02-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
C-$2.01-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA